Literature DB >> 10472463

Sensitivity, specificity and predictive value of tympanometry in predicting a hearing impairment in otitis media with effusion. MRC Multi-Centre Otitis Media Study Group.

.   

Abstract

Children with otitis media with effusion (OME) need monitoring over time to identify persistence of disease and to assess their hearing thresholds as a surrogate of auditory disability. It would be useful if tympanometry could be used to predict those with an impairment. This study looked at 1153 children, aged between 3.25 and 6.75 years, referred for suspected OME. The inclusion of type C2 tympanograms with type B tympanograms versus all other tympanogram types increased the sensitivity of detecting air-conduction thresholds and air-bone gaps of various magnitudes in the better hearing ear but lowered the specificity and the positive predictive value. Extending the pressure range to -600 daPa and excluding the 30% of children with poor concentration on audiometry made no difference to the sensitivity and specificity. The results were the same for the poorer hearing ear. These findings are of practical help in monitoring children with OME. Thus taking an air-conduction average of 25 dB HL in the better ear as the level needing detection, if all children are audiometrically assessed then 100% of those with an impairment will be identified. Limiting audiometry to those with a bilateral type B tympanogram reduces the workload by 50%, but 90% of impaired children will still be detected. Limiting audiometry to those with type B or C2 tympanograms reduces the workload to 69% of the sample, and 95% of impaired children will be identified. With such data, decisions as to how to allocate limited audiometric resources for monitoring children with OME are made easier.

Entities:  

Mesh:

Year:  1999        PMID: 10472463     DOI: 10.1046/j.1365-2273.1999.00259.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  7 in total

1.  Mapping analyses to estimate health utilities based on responses to the OM8-30 Otitis Media Questionnaire.

Authors:  Helen Dakin; Stavros Petrou; Mark Haggard; Sarah Benge; Ian Williamson
Journal:  Qual Life Res       Date:  2009-11-26       Impact factor: 4.147

2.  Wideband aural acoustic absorbance predicts conductive hearing loss in children.

Authors:  Douglas H Keefe; Chris A Sanford; John C Ellison; Denis F Fitzpatrick; Michael P Gorga
Journal:  Int J Audiol       Date:  2012-10-16       Impact factor: 2.117

Review 3.  Identification of children in the first four years of life for early treatment for otitis media with effusion.

Authors:  S A Simpson; C L Thomas; M K van der Linden; H Macmillan; J C van der Wouden; C Butler
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses.

Authors:  Angela Yarnell Bonino; Lori J Leibold
Journal:  J Vis Exp       Date:  2017-01-23       Impact factor: 1.355

5.  Transmastoid Ultrasound Detection of Middle Ear Effusion and Its Association with Clinical Audiometric Tests.

Authors:  Chin-Kuo Chen; Yung-Liang Wan; Li-Chun Hsieh; Po-Hsiang Tsui
Journal:  Life (Basel)       Date:  2022-04-18

6.  INFLATE: a protocol for a randomised controlled trial comparing nasal balloon autoinflation to no nasal balloon autoinflation for otitis media with effusion in Aboriginal and Torres Strait Islander children.

Authors:  Robyn Walsh; Jennifer Reath; Hasantha Gunasekera; Amanda Leach; Kelvin Kong; Deborah Askew; Federico Girosi; Wendy Hu; Timothy Usherwood; Sanja Lujic; Geoffrey Spurling; Peter Morris; Chelsea Watego; Samantha Harkus; Cheryl Woodall; Claudette Tyson; Letitia Campbell; Sylvia Hussey; Penelope Abbott
Journal:  Trials       Date:  2022-04-14       Impact factor: 2.728

7.  The Etiology, Pathophysiology, and Management of Otitis Media with Effusion.

Authors:  Christopher C. Butler; R. Gareth Williams
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.